Fergus Shanahan

Fergus Shanahan's AcademicInfluence.com Rankings

Fergus Shanahan

Philosophy

#2928

World Rank

#4850

Historical Rank

Logic

#858

World Rank

#1415

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Fergus Shanahan's Degrees

Masters Medicine National University of Ireland
Doctorate Medicine National University of Ireland

Why Is Fergus Shanahan Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Fergus Shanahan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Gut microbiota composition correlates with diet and health in the elderly (2012) (2578)
The gut flora as a forgotten organ (2006) (2376)
Composition, variability, and temporal stability of the intestinal microbiota of the elderly (2010) (1431)
Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. (2005) (1392)
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner (2013) (1295)
The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand (1996) (957)
In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. (2001) (951)
Exercise and associated dietary extremes impact on gut microbial diversity (2014) (868)
Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models (2010) (812)
Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome (2006) (776)
The role of substance P in inflammatory disease (2004) (722)
Microbiota is essential for social development in the mouse (2013) (620)
Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? (2006) (582)
Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? (1994) (568)
Enterotypes in the landscape of gut microbial community composition (2017) (561)
Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. (2007) (546)
A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. (1990) (506)
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance (2003) (469)
Tumour-associated and non-tumour-associated microbiota in colorectal cancer (2016) (458)
Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection (2012) (438)
Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials (1999) (438)
Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. (1985) (435)
Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut (2014) (432)
Regulation of prefrontal cortex myelination by the microbiota (2016) (413)
The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia. (2000) (388)
Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. (1993) (371)
Commensal-Induced Regulatory T Cells Mediate Protection against Pathogen-Stimulated NF-κB Activation (2008) (368)
Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. (2001) (364)
Crohn’s disease: factors associated with exposure to high levels of diagnostic radiation (2008) (351)
The oral microbiota in colorectal cancer is distinctive and predictive (2017) (348)
Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor (2011) (344)
The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. (1998) (340)
Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon (2010) (339)
Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. (1991) (334)
The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level (2017) (332)
World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. (2012) (327)
The host-microbe interface within the gut. (2002) (321)
Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius (2006) (317)
Probiotic impact on microbial flora, inflammation and tumour development in IL‐10 knockout mice (2001) (310)
Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease (2006) (308)
Adult Hippocampal Neurogenesis Is Regulated by the Microbiome (2015) (303)
Exploring the Diversity of the Bifidobacterial Population in the Human Intestinal Tract (2009) (300)
Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut (2013) (297)
Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases (2008) (294)
Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. (1991) (289)
Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission (2013) (288)
p53 is frequently mutated in Burkitt's lymphoma cell lines. (1991) (273)
The gut microbiota and its relationship to diet and obesity (2012) (269)
Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity (2012) (268)
Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia (1991) (262)
Distinct associations of HLA class II genes with inflammatory bowel disease. (1993) (260)
The Fas counterattack: cancer as a site of immune privilege. (1999) (251)
Irritable Bowel Syndrome–Type Symptoms in Patients With Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation? (2010) (250)
A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome (2010) (249)
Inflammatory Bowel Disease: From Bench to Bedside (1994) (245)
Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. (2008) (245)
Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells (2011) (243)
Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents (2020) (243)
Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. (2011) (228)
Adult microbiota‐deficient mice have distinct dendritic morphological changes: differential effects in the amygdala and hippocampus (2016) (227)
Multireplicon genome architecture of Lactobacillus salivarius. (2006) (226)
Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats (2014) (226)
Categorization of the gut microbiota: enterotypes or gradients? (2012) (220)
Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. (1997) (218)
Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study. (1991) (215)
Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene (2016) (212)
Bacterial strain‐specific induction of Foxp3+ T regulatory cells is protective in murine allergy models (2010) (210)
Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis (2004) (210)
Probiotics and inflammatory bowel disease: is there a scientific rationale? (2000) (205)
Clostridium difficile Carriage in Elderly Subjects and Associated Changes in the Intestinal Microbiota (2011) (203)
Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis (1995) (203)
Bacteriophages ϕMR299-2 and ϕNH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells (2012) (202)
Differential Expression of Toll-Like Receptors in Patients With Irritable Bowel Syndrome (2011) (200)
Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. (1995) (199)
Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. (1992) (198)
Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers (2015) (197)
Microbes & neurodevelopment – Absence of microbiota during early life increases activity-related transcriptional pathways in the amygdala (2015) (197)
Bacterial DNA within Granulomas of Patients with Crohn's Disease—Detection by Laser Capture Microdissection and PCR (2004) (194)
The microbiota in inflammatory bowel disease (2015) (191)
The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients in Remission (2009) (187)
Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. (2003) (182)
Crohn's disease (2002) (179)
Movers and shakers (2013) (178)
Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. (1999) (178)
Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues. (2009) (178)
Inclusion of the Mesentery in Ileocolic Resection for Crohn’s Disease is Associated With Reduced Surgical Recurrence (2018) (178)
Probiotic effects on inflammatory bowel disease. (2007) (176)
Human methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysis (2008) (175)
Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. (1996) (174)
Immune privilege or inflammation? Insights into the Fas ligand enigma (2001) (174)
Plasma Cytokine Profiles in Females With Irritable Bowel Syndrome and Extra-Intestinal Co-Morbidity (2010) (174)
Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains. (2007) (173)
Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies. (2014) (170)
Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8 (2011) (167)
Mucosal cytokine imbalance in irritable bowel syndrome (2008) (164)
Triggered human mucosal T cells release tumour necrosis factor‐alpha and interferon‐gamma which kill human colonic epithelial cells (1991) (152)
An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease (1999) (147)
PCR detection of Mycobacterium paratuberculosis in Crohn’s disease granulomas isolated by laser capture microdissection (2002) (143)
Enhanced Cholinergic-Mediated Increase in the Pro-Inflammatory Cytokine IL-6 in Irritable Bowel Syndrome: Role of Muscarinic Receptors (2008) (143)
A randomized, placebo‐controlled trial of calcium supplementation for decreased bone density in corticosteroid‐using patients with inflammatory bowel disease: a pilot study (1996) (141)
Pathways of activation of the Epstein-Barr virus productive cycle (1991) (139)
Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation (2000) (139)
The microbiome regulates amygdala-dependent fear recall (2017) (139)
Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. (1995) (138)
The normal intestinal microbiota (2007) (137)
Targeting the Microbiota to Address Diet-Induced Obesity: A Time Dependent Challenge (2013) (133)
Probiotics in inflammatory bowel disease--therapeutic rationale and role. (2004) (133)
Microbiomic analysis of the bifidobacterial population in the human distal gut (2009) (133)
Quantification of the placebo response in ulcerative colitis. (1997) (132)
High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus. (1997) (132)
Exercise and the microbiota (2015) (130)
Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer (1998) (129)
Gut microbiota: mining for therapeutic potential. (2007) (128)
Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer (1999) (126)
Probiotics in obese pregnancy do not reduce maternal fasting glucose: a double-blind, placebo-controlled, randomized trial (Probiotics in Pregnancy Study). (2014) (120)
Probiotics: Towards demonstrating efficacy (1999) (118)
Microbial regulation of microRNA expression in the amygdala and prefrontal cortex (2017) (118)
Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease (2020) (115)
The evolving epidemiology of inflammatory bowel disease (2009) (115)
Feeding the microbiota: transducer of nutrient signals for the host (2017) (114)
Mechanisms of Action of Probiotics in Intestinal Diseases (2006) (111)
Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications. (2003) (111)
A Randomized Controlled Study of Mesalamine After Acute Diverticulitis: Results of the DIVA Trial (2013) (110)
Coeliac disease and epilepsy. (1998) (110)
Altered Mechanisms of Apoptosis in Colon Cancer: Fas Resistance and Counterattack in the Tumor‐Immune Conflict (2000) (110)
Culture-independent analysis of desulfovibrios in the human distal colon of healthy, colorectal cancer and polypectomized individuals. (2009) (109)
Insulin-dependent diabetes mellitus and coeliac disease (1997) (108)
Micrometastases: marker of metastatic potential or evidence of residual disease? (1997) (108)
A Prospective Metagenomic and Metabolomic Analysis of the Impact of Exercise and/or Whey Protein Supplementation on the Gut Microbiome of Sedentary Adults (2018) (107)
Helicobacter pylori Modulates Lymphoepithelial Cell Interactions Leading to Epithelial Cell Damage through Fas/Fas Ligand Interactions (2000) (107)
Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon‐gamma, severity of symptoms and psychiatric co‐morbidity (2008) (106)
Impact of probiotics in women with gestational diabetes mellitus on metabolic health: a randomized controlled trial. (2015) (106)
Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. (2006) (105)
Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. (2012) (105)
Induction and Activation of Adaptive Immune Populations During Acute and Chronic Phases of a Murine Model of Experimental Colitis (2010) (103)
Identification of TLR10 as a Key Mediator of the Inflammatory Response to Listeria monocytogenes in Intestinal Epithelial Cells and Macrophages (2013) (103)
The Healthy Microbiome (What is the definition of a healthy gut microbiome?). (2020) (103)
The altered gut microbiota in adults with cystic fibrosis (2017) (102)
Gut microbiota and obesity: role in aetiology and potential therapeutic target. (2014) (102)
Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population (1999) (101)
Portrait of an immunoregulatory bifidobacterium (2012) (100)
The gut microbiota—a clinical perspective on lessons learned (2012) (99)
Microbiota regulates visceral pain in the mouse (2017) (99)
Probiotics in perspective. (2010) (98)
IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation (2016) (95)
Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption. (2019) (94)
Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. (2009) (93)
Bacterial bile salt hydrolase in host metabolism: Potential for influencing gastrointestinal microbe-host crosstalk (2014) (93)
Is nutrition an aetiological factor for inflammatory bowel disease? (2003) (93)
Production of interleukin-1 by microglia in response to substance P: role for a non-classical NK-1 receptor (1993) (92)
Seasonality of vitamin D status and bone turnover in patients with Crohn's disease (2005) (91)
Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory (2013) (90)
Celiac disease and irritable bowel-type symptoms (2002) (90)
Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease. (2005) (89)
Coeliac disease and autoimmune Addison's disease: a clinical pitfall. (2002) (89)
Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo. (2005) (88)
Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome. (2011) (87)
Biological behaviour and clinical implications of micrometastases (2000) (87)
Gut microbiota alterations associated with reduced bone mineral density in older adults (2019) (87)
IBS: an epigenetic perspective (2010) (87)
Tumour necrosis factor 5′ promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families (2001) (87)
Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study (2020) (86)
Probiotics: an emerging therapy. (2005) (86)
Fas counter-attack–the best form of tumor defense? (1999) (86)
Celiac disease and irritable bowel-type symptoms. (2002) (86)
Therapeutic Manipulation of Gut Flora (2000) (85)
A prospective comparison of laparoscopy and imaging in the staging of esophagogastric cancer before surgery. (1995) (85)
Celiac Disease and the Transition from Childhood to Adulthood: A 28-Year Follow-Up (2004) (84)
Association of NOD2 with Crohn's Disease in a homogenous Irish population (2003) (84)
Probiotic Colonization of the Adherent Mucus Layer of HT29MTXE12 Cells Attenuates Campylobacter jejuni Virulence Properties (2010) (84)
The colonic microbiota in health and disease (2013) (82)
Viral clearance in hepatitis C (1b) infection: Relationship with human leukocyte antigen class II in a homogeneous population (2000) (82)
The Mycobacteria Story in Crohn's Disease (2005) (81)
Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis (2013) (80)
Mechanism of protection of transepithelial barrier function by Lactobacillus salivarius: strain dependence and attenuation by bacteriocin production. (2012) (80)
Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future (2002) (79)
Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice. (2015) (79)
Unconjugated Bile Acids Influence Expression of Circadian Genes: A Potential Mechanism for Microbe-Host Crosstalk (2016) (78)
Increased neutrophil receptors for and response to the proinflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine in Crohn's disease. (1989) (78)
Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells (2004) (75)
Mast cell heterogeneity. (1983) (75)
Investigation of the Genetic Influence of the OPG, VDR (Fok1), and COLIA1 Sp1 Polymorphisms on BMD in the Irish Population (2002) (75)
Radiologic imaging in cystic fibrosis: cumulative effective dose and changing trends over 2 decades. (2012) (74)
Review article: dietary fibre in the era of microbiome science (2019) (73)
Immunologic mechanisms in intestinal diseases. (1987) (72)
Exopolysaccharide-producing probiotic Lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient mice. (2014) (72)
Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E−/− mice (2017) (72)
Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: molecular quantitation and localization. (1998) (71)
Coeliac disease and diabetes mellitus: a study of 24 patients with HLA typing. (1982) (70)
Host–Flora Interactions in Inflammatory Bowel Disease (2004) (69)
Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use (2006) (69)
Vitamin K Status in Patients with Crohn's Disease and Relationship to Bone Turnover (2004) (69)
Yamada's textbook of gastroenterology / (2015) (69)
Role of interleukin (IL‐10) in probiotic‐mediated immune modulation: an assessment in wild‐type and IL‐10 knock‐out mice (2006) (68)
The Fas Counterattack: A Molecular Mechanism of Tumor Immune Privilege (1997) (66)
Degradation of the extracellular matrix components by bacterial‐derived metalloproteases: Implications for inflammatory bowel diseases (2011) (65)
Anemia in patients with chronic inflammatory bowel disease (2001) (65)
Thromboembolism—an Important Manifestation of Inflammatory Bowel Disease (2004) (65)
Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn’s Disease and Ulcerative Colitis (2018) (64)
Pathogenesis of ulcerative colitis (1993) (64)
Impact of Administered Bifidobacterium on Murine Host Fatty Acid Composition (2010) (64)
Interferon‐γ sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis (2000) (64)
HLA class II genes determine the natural variance of hepatitis C viral load (2001) (63)
Involvement of T helper type 17 and regulatory T cell activity in Citrobacter rodentium invasion and inflammatory damage (2009) (62)
CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra‐Low‐Dose Chest CT Scores After CFTR Modulation With Ivacaftor (2017) (62)
Prevalence and severity of periodontal disease in patients with inflammatory bowel disease. (1991) (62)
Social interaction-induced activation of RNA splicing in the amygdala of microbiome-deficient mice (2018) (62)
Nutrient tasting and signaling mechanisms in the gut V. Mechanisms of immunologic sensation of intestinal contents. (2000) (61)
Fas ligand upregulation is an early event in colonic carcinogenesis (2001) (61)
Probiotics in inflamatory bowel disease (2001) (61)
A commentary on the safety of probiotics. (2012) (60)
Brain-gut axis and mucosal immunity: a perspective on mucosal psychoneuroimmunology. (1999) (60)
Manipulation of the bacterial flora in inflammatory bowel disease. (2003) (59)
Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system. (2013) (59)
Milk tolerance in adults with ulcerative colitis. (1994) (59)
Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model (2008) (59)
American Gastroenterological Association medical position statement: guidelines for the evaluation of food allergies. (2001) (58)
Selected summary: Feagan BG, McDonald JWD, Rochon J, et al. for the Canadian Crohn's Relapse Prevention Trial Investigators. Low-dose cyclosporine for the treatment of Crohn's disease. N Engl J Med 1994; 330:1846–1851 (June) (1995) (58)
Hidradenitis suppurativa. Glucose tolerance, clinical, microbiologic, and immunologic features and HLA frequencies in 27 patients. (1988) (58)
Epstein-Barr virus SM protein. (1994) (58)
The influence of endorphins on peritoneal and mucosal mast cell secretion. (1984) (58)
Mycobacterium avium subsp. Paratuberculosis (MAP) as a modifying factor in Crohn's disease (2010) (57)
Pregnancy and pregnancy outcome in hepatitis C type 1b. (2000) (57)
Expression of Fas (CD95/APO-1) Ligand by Human Breast Cancers: Significance for Tumor Immune Privilege (1999) (57)
TL1A/TNFSF15 directly induces proinflammatory cytokines, including TNFα, from CD3+CD161+ T cells to exacerbate gut inflammation (2012) (56)
Gut Microbes: From Bugs to Drugs (2010) (56)
Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria (2009) (56)
Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection (2018) (56)
Micrometastases in bone marrow of patients undergoing "curative" surgery for gastrointestinal cancer. (1995) (56)
Sulfasalazine inhibits the binding of TNFα to its receptor (1990) (56)
Four men in a boat: Ultra-endurance exercise alters the gut microbiome. (2019) (55)
Natural Killer Cells Protect against Mucosal and Systemic Infection with the Enteric Pathogen Citrobacter rodentium (2012) (55)
Correlation of probiotic Lactobacillus salivarius growth phase with its cell wall-associated proteome. (2005) (55)
Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-β expression (2003) (55)
Altered levels of biochemical indices of bone turnover and bone‐related vitamins in patients with Crohn's disease and ulcerative colitis (2006) (54)
The gut microbiome as a modulator of healthy ageing (2022) (54)
Natural killer cells protect mice from DSS-induced colitis by regulating neutrophil function via the NKG2A receptor (2013) (54)
Piphillin predicts metagenomic composition and dynamics from DADA2-corrected 16S rDNA sequences (2020) (52)
World Gastroenterology Organisation practice guideline: Probiotics and prebiotics. (2008) (52)
Diagnostic accuracy of computed tomography using lower doses of radiation for patients with Crohn's disease. (2012) (52)
Gut microbiota modulation and implications for host health: Dietary strategies to influence the gut-brain axis (2014) (51)
Down‐regulation of p38 mitogen‐activated protein kinase activation and proinflammatory cytokine production by mitogen‐activated protein kinase inhibitors in inflammatory bowel disease (2010) (51)
The Gut Microbiota in Inflammatory Bowel Disease. (2017) (51)
Differential expression of key regulators of Toll‐like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator‐activated receptor gamma? (2015) (51)
Recombinant lactobacilli expressing linoleic acid isomerase can modulate the fatty acid composition of host adipose tissue in mice. (2011) (50)
Natural fluctuations of hepatitis C viral load in a homogeneous patient population: A prospective study (2000) (50)
High levels of Lymphotoxin-Beta (LT-Beta) gene expression in rheumatoid arthritis synovium: clinical and cytokine correlations (2008) (50)
Metabolic activity of probiotics-oxalate degradation. (2009) (49)
Protective effects of Lactobacillus rhamnosus [corrected] and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. (2008) (49)
Therapeutic implications of manipulating and mining the microbiota (2009) (49)
Human mucosal cytotoxic effector cells. (1987) (48)
Mast cell heterogeneity. (1984) (47)
Probiotics: A Perspective on Problems and Pitfalls (2003) (47)
Identification of a Unique Hybrid Macrophage-Polarization State following Recovery from Lipopolysaccharide Tolerance (2014) (47)
Differential Expression of Neurokinin-1 Receptor by Human Mucosal and Peripheral Lymphoid Cells (2000) (47)
Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1. (2004) (46)
Portrait of a canine probiotic Bifidobacterium--from gut to gut. (2009) (46)
Constitutive ERK1/2 Activation in Esophagogastric Rib Bone Marrow Micrometastatic Cells Is MEK-independent* (2001) (46)
Neuroimmunomodulation in Inflammatory Bowel Disease: How Far from “Bench” to “Bedside”? a (1998) (46)
Asymptomatic carriage of Clostridium difficile in an Irish continuing care institution for the elderly: prevalence and characteristics (2010) (46)
Regional immunosuppression in esophageal squamous cancer: evidence from functional studies with matched lymph nodes. (1996) (46)
A Randomised Controlled Trial of a Probiotic Lactobacillus Strain in Healthy Adults: Assessment of its Delivery, Transit and Influence on Microbial Flora and Enteric Immunity (2002) (46)
Neurokinin‐1 receptor (NK‐1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P (2003) (45)
The inflammatory response within Dukes’ B colorectal cancers: implications for progression of micrometastases and patient survival (2000) (45)
A Bifidobacterial pilus‐associated protein promotes colonic epithelial proliferation (2018) (45)
Intestinal mucosal mast cells: isolation from rat lamina propria and purification using unit gravity velocity sedimentation. (1985) (44)
Human lung mast cells: distribution and abundance of histochemically distinct subpopulations. (1987) (44)
Inflammatory bowel disease—From mechanisms to treatment strategies (2010) (44)
Targeting the Fas/Fas ligand pathway in cancer (2005) (44)
Modulation of histamine release from canine fundic mucosal mast cells. (1988) (43)
Microbial regulation of hippocampal miRNA expression: Implications for transcription of kynurenine pathway enzymes (2017) (42)
Pharmabiotic manipulation of the microbiota in gastrointestinal disorders, from rationale to reality. (2010) (42)
A prospective feasibility study of sub-millisievert abdominopelvic CT using iterative reconstruction in Crohn’s disease (2013) (42)
Bioavailability of the anti-clostridial bacteriocin thuricin CD in gastrointestinal tract. (2014) (41)
Prevalence and characterization of Clostridium perfringens from the faecal microbiota of elderly Irish subjects. (2013) (40)
Fas Ligand Promotes Tumor Immune Evasion of Colon Cancer In Vivo (2006) (40)
Bifidobacterium breve Bif195 Protects Against Small-intestinal Damage Caused by Acetylsalicylic Acid in Healthy Volunteers. (2019) (39)
Role of radiologic imaging in irritable bowel syndrome: evidence-based review. (2012) (39)
Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells (2008) (39)
Mucosal subepithelial binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP) (1998) (39)
Bifidobacterium Infantis 35624 Protects Against Salmonella-Induced Reductions in Digestive Enzyme Activity in Mice by Attenuation of the Host Inflammatory Response (2012) (38)
Radiation exposure from diagnostic imaging among patients with gastrointestinal disorders. (2012) (38)
The microbiota in inflammatory bowel disease: friend, bystander, and sometime-villain. (2012) (38)
Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo (2010) (38)
Bifidobacterium infantis suppression of Peyer's patch MIP-1α and MIP-1β secretion during Salmonella infection correlates with increased local CD4+CD25+ T cell numbers. (2013) (38)
Suggestive Linkage of 2p22-25 and 11q12-13 with Low Bone Mineral Density at the Lumbar Spine in the Irish Population (2003) (37)
Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack. (1999) (37)
Prevalence of bone marrow micrometastases in esophagogastric cancer patients with and without neoadjuvant chemoradiotherapy. (2004) (37)
Selective influence of host microbiota on cAMP‐mediated ion transport in mouse colon (2014) (37)
Type 1 diabetes mellitus, coeliac disease, and lymphoma: a report of four cases (1999) (36)
Enteric neuropathophysiology and inflammatory bowel disease (1998) (35)
Tissue viral load variability in chronic hepatitis C (2001) (35)
Microbiome and health implications for ethnic minorities after enforced lifestyle changes (2020) (35)
Use of bioluminescence imaging to track neutrophil migration and its inhibition in experimental colitis (2010) (34)
In vivo assessment of potential probiotic Lactobacillus salivarius strains: evaluation of their establishment, persistence, and localisation in the murine gastrointestinal tract (1999) (34)
Modulation of ongoing human immunoglobulin synthesis by natural killer cells. (1987) (34)
Irritable bowel syndrome: shifting the focus toward the gut microbiota. (2007) (34)
Comparative aspects of mast cell heterogeneity in different species and sites. (1985) (34)
Medical treatment of inflammatory bowel disease. (1992) (34)
Increased soluble interleukin 2 receptor levels in schizophrenia (1998) (34)
The survival and colonic adhesion of Bifidobacterium infantis in patients with ulcerative colitis (2002) (33)
Hermansky-Pudlak syndrome: an immunologic assessment of 15 cases. (1988) (33)
A Gut Reaction--Lymphoepithelial Communication in the Intestine (1997) (33)
Human mucosal T-cell cytotoxicity. (1988) (33)
Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo (2003) (33)
The influence of rosuvastatin on the gastrointestinal microbiota and host gene expression profiles. (2017) (33)
Probiotics in transition. (2012) (32)
Neutrophil autoantibodies in inflammatory bowel disease: are they important? (1994) (32)
Immunomodulatory effects of feeding with Bifidobacterium longum on allergen-induced lung inflammation in the mouse. (2012) (32)
Role of probiotics in the treatment of intestinal infections and inflammation (2002) (32)
Immunology and Immunopathology of the Liver and Gastrointestinal Tract (1989) (32)
Exercise, fitness, and the gut (2016) (32)
Screening for asymptomatic celiac disease among patients referred for bone densitometry measurement. (2003) (31)
Translating the gut microbiome: ready for the clinic? (2019) (31)
The gut microbiota in 2011: Translating the microbiota to medicine (2012) (31)
Intestinal tuberculosis mimicking Crohn's disease: lessons relearned in a new era. (2007) (30)
Bcl-xL expression in vivo in rheumatoid synovium (2006) (30)
In vitro replication models for the hepatitis C virus (2007) (29)
Gut microbiota: implications for sports and exercise medicine (2017) (29)
Moderate-intensity aerobic and resistance exercise is safe and favorably influences body composition in patients with quiescent Inflammatory Bowel Disease: a randomized controlled cross-over trial (2019) (29)
Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization. (1987) (29)
Tumour-associated and non-tumour-associated microbiota: Addendum (2018) (29)
Neuroendocrine modulation of the immune system. Possible implications for inflammatory bowel disease. (1988) (29)
Pneumocystis carinii pneumonia in patients with ulcerative colitis treated with corticosteroids. (1993) (28)
Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium: a potential mechanism of apoptotic epithelial turnover. (1999) (28)
The colonic microflora and probiotic therapy in health and disease (2011) (28)
Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection (2020) (28)
Mutagenesis by Microbe: the Role of the Microbiota in Shaping the Cancer Genome. (2020) (28)
The Gut Microbiota in Causation, Detection, and Treatment of Cancer. (2019) (28)
Exploring the Iceberg—the Spectrum of Celiac Disease (2003) (28)
Bifidobacterium breve with α-Linolenic Acid and Linoleic Acid Alters Fatty Acid Metabolism in the Maternal Separation Model of Irritable Bowel Syndrome (2012) (28)
Modelling the major histocompatibility complex susceptibility to RA using the MASC method (1998) (27)
Soluble interleukin 2 receptor levels in families of people with schizophrenia (2002) (27)
The Use of a Mini-Bioreactor Fermentation System as a Reproducible, High-Throughput ex vivo Batch Model of the Distal Colon (2018) (27)
Bone marrow micrometastases and gastrointestinal cancer detection and significance (2000) (27)
Cogan’s syndrome: present and future directions (2009) (27)
The Colonic Microbiota and Colonic Disease (2012) (26)
CD38 is associated with premenopausal and postmenopausal bone mineral density and postmenopausal bone loss (2005) (26)
The gut virome in Irritable Bowel Syndrome differs from that of controls (2021) (26)
Chapter 26 Neurotransmitters and cytokines in CNS pathology (1994) (26)
Bcl‐3 deficiency protects against dextran‐sodium sulphate‐induced colitis in the mouse (2013) (26)
Inferred hepatitis C virus quasispecies diversity is influenced by choice of DNA polymerase in reverse transcriptase-polymerase chain reactions. (2001) (26)
Sulfasalazine inhibits the binding of TNF alpha to its receptor. (1990) (25)
Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes. (1986) (25)
Differential regulation of Toll‐like receptor signalling in spleen and Peyer’s patch dendritic cells (2010) (25)
A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis (2017) (25)
IgG-Mediated Food Intolerance in Irritable Bowel Syndrome: A Real Phenomenon or an Epiphenomenom? (2005) (25)
Antimicrobials: Strategies for targeting obesity and metabolic health? (2013) (25)
Why is Celiac Disease So Common in Ireland? (2001) (25)
Review article: colitis‐associated cancer – time for new strategies (2003) (24)
Concomitant Exposure to Ovalbumin and Endotoxin Augments Airway Inflammation but Not Airway Hyperresponsiveness in a Murine Model of Asthma (2014) (24)
Quantitative measurement of mRNA expression by competitive RT-PCR. (1998) (24)
The Sphingosine-1-Phosphate Analogue FTY720 Impairs Mucosal Immunity and Clearance of the Enteric Pathogen Citrobacter rodentium (2012) (24)
Mechanisms of adherence of a probiotic Lactobacillus strain during and after in vivo assessment in ulcerative colitis patients (2004) (24)
Preparation of a standardised faecal slurry for ex-vivo microbiota studies which reduces inter-individual donor bias. (2016) (24)
Clostridium difficile carriage in adult cystic fibrosis (CF); implications for patients with CF and the potential for transmission of nosocomial infection. (2017) (24)
Food allergy: fact, fiction, and fatality. (1993) (24)
Differential intestinal M‐cell gene expression response to gut commensals (2012) (24)
Activation of the p38 MAPK and ERK1/2 Pathways Is Required for Fas‐Induced IL‐8 Production in Colonic Epithelial Cells (2002) (23)
Relation between colitis and colon cancer (2001) (23)
The small bowel microbiota (2015) (23)
Addison disease in patients treated with glucocorticoid therapy. (1997) (23)
Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Corrects article in Vol 10 (3) pages 789-798 (2008) (22)
Molecular mechanisms of probiotic action: it's all in the strains! (2011) (22)
Drug Interactions in Inflammatory Bowel Disease (2008) (22)
Depth-Dependent Differences in Community Structure of the Human Colonic Microbiota in Health (2013) (22)
Language, numeracy and logic in microbiome science (2019) (22)
Sulfasalazine and salicylate-induced exacerbation of ulcerative colitis. (1987) (21)
Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicity (1994) (21)
Mast cell heterogeneity: effect of anti-allergic compounds on neuropeptide-induced histamine release. (1986) (21)
Fiber man meets microbial man. (2015) (21)
Inflammatory Bowel Disease: Translating Basic Science into Clinical Practice (2010) (21)
The fecal mycobiome in patients with Irritable Bowel Syndrome (2021) (21)
Turbo probiotics for IBD. (2001) (20)
Digestion of epithelial tight junction proteins by the commensal Clostridium perfringens. (2012) (20)
Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer (2013) (20)
Fas ligand expression in human and mouse cancer cell lines; a caveat on over-reliance on mRNA data (2006) (20)
Extended-culture and culture-independent molecular analysis of the airway microbiota in cystic fibrosis following CFTR modulation with ivacaftor. (2021) (20)
Altered Skin and Gut Microbiome in Hidradenitis Suppurativa. (2021) (20)
TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells (2021) (20)
Antibody 'markers' in Crohn's disease: opportunity or overstatement? (1997) (20)
Genetic analysis of the 3′ untranslated region of the tumour necrosis factor shows a highly conserved region in rheumatoid arthritis affected and unaffected subjects (1999) (20)
Gastric digestion of α-lactalbumin in adult human subjects using capsule endoscopy and nasogastric tube sampling (2014) (20)
Model-Based Iterative Reconstruction in CT Enterography. (2015) (19)
Gut flora in gastrointestinal disease. (2002) (19)
Carbohydrate Syntrophy enhances the establishment of Bifidobacterium breve UCC2003 in the neonatal gut (2018) (19)
Intestinal lymphoepithelial communication. (1999) (19)
Quantitative analysis of mucosal oxygenation using ex vivo imaging of healthy and inflamed mammalian colon tissue (2016) (19)
Anemia in patients with chronic inflammatory bowel disease. (2001) (19)
Minimization of Radiation Exposure due to Computed Tomography in Inflammatory Bowel Disease (2012) (19)
Effect of phylloquinone (vitamin K1) supplementation for 12 months on the indices of vitamin K status and bone health in adult patients with Crohn's disease (2014) (19)
A randomised, double-blind, placebo-controlled clinical study: the effects of a synbiotic, Lepicol, in adults with chronic, functional constipation (2017) (18)
MALTectomy (appendectomy/tonsillectomy) does not influence the occurrence or mode of presentation of adult celiac disease. (1996) (18)
Salmonella typhimurium stimulation combined with tumour‐derived heat shock proteins induces potent dendritic cell anti‐tumour responses in a murine model (2007) (18)
Host–microbe interactions and spatial variation of cancer in the gut (2014) (18)
Role of mucosal T-cell-generated cytokines in epithelial cell injury (1991) (18)
The future of probiotics for disorders of the brain-gut axis. (2014) (18)
Current concepts of the pathogenesis of inflammatory bowel disease (1994) (18)
Fast Facts: Inflammatory Bowel Disease (2020) (18)
Microbial contributions to chronic inflammation and metabolic disease (2016) (18)
Do Taq‐generated RT‐PCR products from RNA viruses accurately reflect viral genetic heterogeneity? (2004) (18)
The prophylactic use of a proton pump inhibitor before food and alcohol (2003) (18)
Technical Advance: Function and efficacy of an α4‐integrin antagonist using bioluminescence imaging to detect leukocyte trafficking in murine experimental colitis (2010) (17)
Increased risk of miscarriage and ectopic pregnancy among women with irritable bowel syndrome. (2012) (17)
The hybrid science of diet, microbes, and metabolic health. (2011) (17)
Food, GI-tract Functionality and Human Health Cluster: PROEUHEALTH (2002) (17)
Extending the scope in celiac disease. (1988) (17)
99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Host–microbe interactions in the gut: target for drug therapy, opportunity for drug discovery (2010) (17)
The language of medicine: words as servants and scoundrels. (2009) (17)
Ulcerative colitis-linked antineutrophil cytoplasmic antibody in the cotton-top tamarin model of colitis. (1992) (17)
Carriage of Clostridium difficile in outpatients with irritable bowel syndrome. (2012) (16)
Bacterial signalling overrides cytokine signalling and modifies dendritic cell differentiation (2009) (16)
Mycobacterium paratuberculosis detected by nested PCR in intestinal granulomas isolated by LCM in cases of Crohn's disease. (2002) (16)
Bifidobacterium breve with α-linolenic acid alters the composition, distribution and transcription factor activity associated with metabolism and absorption of fat (2017) (16)
Probiotics in Inflammatory Bowel Disease (2006) (16)
Yamada's Atlas of Gastroenterology (2016) (16)
Odd forms of inflammatory bowel disease: what can they tell us? (1993) (15)
Evaluation of colostrum-derived human mammary-associated serum amyloid A3 (M-SAA3) protein and peptide derivatives for the prevention of enteric infection: in vitro and in murine models of intestinal disease. (2009) (15)
Neutrophil autoantibodies as disease markers for ulcerative colitis (1991) (15)
Immunological and genetic links in Crohn's disease (2000) (15)
Minimization of radiation exposure due to computed tomography in inflammatory bowel disease. (2011) (15)
Neuroendocrine modulation of the immune system (1988) (15)
Publisher Correction: Enterotypes in the landscape of gut microbial community composition (2018) (14)
Enhanced neutrophil chemiluminescence in familial mediterranean fever (1988) (14)
Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies (2023) (14)
The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial. (2019) (14)
Separating the microbiome from the hyperbolome (2015) (14)
The role of pure iterative reconstruction in conventional dose CT enterography (2015) (14)
Steroid allergy in patients with inflammatory bowel disease (2007) (13)
Low-dose CT imaging of the acute abdomen using model-based iterative reconstruction: a prospective study (2018) (13)
Defining gastrointestinal transit time using video capsule endoscopy: a study of healthy subjects (2020) (13)
Critical appraisal of enteral nutrition as primary therapy in adults with Crohn's disease. (1996) (13)
Functional foods and probiotics: Time for gastroenterologists to embrace the concept (2000) (13)
The Changing Phenotype of Inflammatory Bowel Disease (2016) (13)
Enteric Microbiota and Small Intestinal Bacterial Overgrowth (2010) (13)
Darwinian Dyspepsia: An Extraordinary Scientist, an Ordinary Illness, Great Dignity (2012) (13)
Progress in treating esophageal adenocarcinoma. (1997) (13)
Efficacy of Delayed-Release Mesalamine in the Prevention of GI Symptoms Following Acute Diverticulitis: Results of the DIVA Trial: 377 (2010) (13)
Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines. (1994) (13)
Human BCL-G regulates secretion of inflammatory chemokines but is dispensable for induction of apoptosis by IFN-γ and TNF-α in intestinal epithelial cells (2020) (12)
Anti‐TNF Therapy for Crohn's Disease: A Perspective (Infliximab Is Not the Drug We Have Been Waiting For) (2000) (12)
Nested RT-PCR. Sensitivity controls are essential to determine the biological significance of detected mRNA. (2002) (12)
Plain abdominal radiographs in patients with Crohn's disease: radiological findings and diagnostic value. (2012) (12)
Neurotransmitters and cytokines in CNS pathology. (1994) (12)
Undiagnosed maternal celiac disease in pregnancy and an increased risk of fetal growth restriction. (2009) (12)
Invasion by esophageal cancer cells: functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor (1999) (12)
The prevalence of coeliac disease among female subjects having bone densitometry (2002) (11)
Computed Tomography Assessment of Intestinal Gas Volumes in Functional Gastrointestinal Disorders (2012) (11)
The effects of sustained fitness improvement on the gut microbiome: A longitudinal, repeated measures case‐study approach (2020) (11)
Prognostic significance of prospectively detected bone marrow micrometastases in esophagogastric cancer: 10-year follow-up confirms prognostic significance (2015) (11)
Type I Insulin‐like Growth Factor Receptor Expression on Colorectal Adenocarcinoma Cell Lines Is Decreased in Response to the Chemopreventive Agent N‐Acetyl‐l‐Cysteine (2002) (11)
Genotoxicity of Fecal Water in a Free-Living Irish Population (2002) (11)
Biotinylation of a bombesin/gastrin-releasing peptide analogue for use as a receptor probe (1991) (11)
The inflammatory response within Dukes' B colorectal cancers: implications for progression of micrometastases and patient survival. (2000) (11)
Detection of Mycobacterium avium subspecies paratuberculosis in patients with Crohn’s disease is unrelated to the presence of single nucleotide polymorphisms rs2241880 (ATG16L1) and rs10045431 (IL12B) (2014) (11)
Shining a Light on Intestinal Traffic (2011) (11)
The gut microbiota and disease – an inner repository for drug discovery (2007) (11)
Irritable Bowel Syndrome – Type Symptoms in Patients With Infl ammatory Bowel Disease : A Real Association or Refl ection of Occult Infl ammation ? (2010) (10)
Development of a biotinylated analog of substance P for use as a receptor probe. (1991) (10)
Viral load change and sequential evolution of entire hepatitis C virus genome in Irish recipients of single source‐contaminated anti‐D immunoglobulin * (2005) (10)
Mycobacterium avium susp. paratuberculosis (MAP) and the food chain (2005) (10)
The role of autoantibodies and autoimmunity in chronic inflammatory disorders of the gut (1992) (10)
Selection of Symptomatic Patients with Crohn's Disease for Abdominopelvic Computed Tomography: Role of Serum C-Reactive Protein (2012) (10)
Risk factors for hand injury in hurling: a cross-sectional study (2013) (10)
The CD8+ Leu‐7+ subset of T cells in Crohn's disease: distinction between cytotoxic and covert suppressor functions (1990) (10)
Discontent with Dysplasia Surveillance in Ulcerative Colitis (1995) (10)
Upregulation of Neurokinin-1 Receptor Expression in the Lungs of Patients with Sarcoidosis (2003) (10)
A strategy for obtaining near full-length HCV cDNA clones (assemblicons) by assembly PCR. (2005) (9)
Probiotics and the Immune Response: How Much Can We Expect? (2004) (9)
Immune-Mediated Cytotoxicity in Inflammatory Bowel Disease (1990) (9)
Infliximab therapy for complicated sarcoidosis. (2002) (9)
CON: Surveillance for Ulcerative Colitis-Associated Cancer: Time to Change the Endoscopy and the Microscopy (2004) (9)
Investigating the Role of Diet and Exercise in Gut Microbe-Host Cometabolism (2020) (8)
Probiotics, mononuclear cells, and epithelial cells: An anti-inflammatory network (2000) (8)
Antibiotics as a first-line therapy for Crohn's disease: is there any consensus? (2004) (8)
Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis (2021) (8)
An unusual phenotype in Muckle-Wells syndrome associated with NLRP3 E311K. (2011) (8)
Genes, bacteria, and T cells: ingredients for inflammatory bowel disease. (1998) (8)
GREB1 genetic variants are associated with bone mineral density in Caucasians (2018) (8)
Understanding symptoms and signs in inflammatory bowel disease (2005) (8)
Esophageal intramural pseudodiverticulosis characterized by barium esophagography: a case report (2010) (8)
Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel disease (2004) (8)
Host Microbiota Regulates Central Nervous System Serotonin Receptor 2C Editing in Rodents. (2019) (8)
Mucosal substance P receptor expression in HIV infection and inflammatory bowel disease. (1997) (8)
Systemic Inflammatory Markers and Disease Severity in Chronic Obstructive Pulmonary Disease—The Effect of Acute Exercise and Pulmonary Rehabilitation (2015) (8)
CT‐based estimation of intracavitary gas volumes using threshold‐based segmentation: In vitro study to determine the optimal threshold range (2012) (8)
Medicine in the Age of " Ulysses ": James Joyce's portrait of life, medicine, and disease on a Dublin day a century ago (2006) (8)
Erratum to: The altered gut microbiota in adults with cystic fibrosis (2017) (7)
Colonoscopy during an attack of severe ulcerative colitis. (1991) (7)
The Role of T‐Cell Receptor β Chain Genes in the Susceptibility to Rheumatoid Arthritis (1995) (7)
Probiotics in Irritable Bowel Syndrome (2010) (7)
Are patients with IBD knowledgeable about the risks of their medications? (2008) (7)
Oral immune tolerance to tumor specific antigens may confer growth advantage to esophageal and gastric cancers. (2003) (7)
Impaired cognitive function in Crohn’s disease: Relationship to disease activity (2020) (7)
Braving the elementals in Crohn's disease. (1992) (7)
Managing chronic disease in Ireland: hospital admission rates and clinical outcomes in a large ulcerative colitis population (2012) (7)
Pure Iterative Reconstruction Improves Image Quality in Computed Tomography of the Abdomen and Pelvis Acquired at Substantially Reduced Radiation Doses in Patients With Active Crohn Disease (2016) (7)
Factor XIII: is it a factor in Crohn's disease? (1993) (7)
VIP modulates intracellular calcium oscillations in human lymphoblasts. (1993) (6)
Neurokinin-1 Receptor ( NK1 R ) Expression is Induced in Human Colonic Epithelial Cells by Proinflammatory Cytokines and Mediates Proliferation in Response to Substance (2003) (6)
Functional characterization of mast cells generated in vitro from the mesenteric lymph node of rats infected with Nippostrongylus brasiliensis. (1986) (6)
Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges (2011) (6)
IMMUNOLOGICAL TESTS TO MONITOR INFLAMMATORY BOWEL DISEASE—HAVE THEY DELIVERED YET? (1998) (6)
Encapsulated cyclosporine does not change the composition of the human microbiota when assessed ex vivo and in vivo. (2020) (6)
Dietary Fiber and Gastrointestinal Disease: an Evolving Story (2018) (6)
PPO.19 Probiotics in obese pregnancy to reduce maternal fasting glucose: A randomised controlled trial (2014) (6)
Immunosuppressive and Immunomodulatory Therapy for Inflammatory Bowel Disease (1993) (6)
Fas-mediated apoptosis in autoimmune and Helico-bacter pylori-associated gastritis* (1998) (6)
Histological patchiness and sparing of the rectum in ulcerative colitis: refuting the dogma. (1997) (6)
The emerging role of the microbial-gastrointestinal-neural axis (2009) (6)
Original ContributionsAn international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease (1999) (6)
Cerebral intravascular coagulation complicating diabetic ketoacidosis (1981) (6)
Lack of an association between polymorphisms of the T-cell receptor α-chain and ulcerative colitis (1989) (6)
Appendectomy, mucosal immunity, and colitis. (1997) (6)
Probiotics, prebiotics, and inflammatory bowel disease. (2007) (5)
Piphillin predicts metagenomic composition and dynamics from DADA2-corrected 16S rDNA sequences (2020) (5)
Influence of gut microbiota and manipulation by probiotics and prebiotics on host tissue fat: Potential clinical implications (2012) (5)
Increased health burden associated with Clostridium difficile diarrhoea in inflammatory bowel disease (2011) (5)
Turning on T-cell death and turning off Crohn's disease. (2000) (5)
Microbiome alterations in IBS (2020) (5)
Toward an improved definition of a healthy microbiome for healthy aging (2022) (5)
Exercise-induced bronchoconstriction and exercise testing in an international rugby union team (2010) (5)
K562 killing by K, IL 2-responsive NK, and T cells involves different effector cell post-binding trigger mechanisms. (1986) (5)
Soluble interleukin 2 receptor levels in acute and stable schizophrenia (2001) (5)
Correction to: Piphillin predicts metagenomic composition and dynamics from DADA2- corrected 16S rDNA sequences (2020) (5)
A significant step in the celiac puzzle. (1998) (5)
James Joyce and gastroenterology. (2008) (5)
Probiotic human bifidobacteria: Selection of a new strain and evaluation in vitro and in vivo (2000) (5)
Type 1 diabetes mellitus, coeliac disease, and lymphoma (1999) (5)
Making microbes work for mankind--clever trick or a glimpse of the future for IBD treatment? (2004) (5)
Changing the narrative on antibiotics (2015) (5)
Metagenomic assembled plasmids of the human microbiome vary across disease cohorts (2022) (5)
Sarcoidosis, the pancreas, and diabetes mellitus. (1995) (5)
attenuates Campylobacter jejuni virulence properties. (2010) (5)
Interleukin 8, neutrophils, and acute inflammation. (1992) (5)
Antimicrobials (2013) (5)
Mapping the colorectal tumor microbiota (2021) (5)
Probiotic bacteria and pathogenic bacteria ellicit differential cytokine responses from dendrictic cells (2001) (4)
Macronutrients, microbiome and precision nutrition (2020) (4)
Immunology of Inflammatory Bowel Disease (1989) (4)
Microbes and metabolic health (2012) (4)
Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for) (2000) (4)
Colorectal microbiota after removal of colorectal cancer (2022) (4)
Metronidazole in Crohn's disease: what's the score? (1992) (4)
Clinical Dilemmas in Inflammatory Bowel Disease (2011) (4)
Perplexing plain abdominal x-ray (2010) (4)
Irritable Bowel Syndrome and Inflammatory Bowel Disease: Is There an Overlap? (2010) (4)
ANCAs aweigh in colitis. (1993) (4)
Esophagogastric cancer--time to change the paradigm. (2000) (4)
Mucosal Cytokine Imbalance in Irritable Bowel Syndrome (IBS): 1082 (2007) (4)
26 – Probiotics in inflammatory bowel disease (2004) (4)
An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease (IBD) (1998) (4)
Setback for systemic therapy of esophageal cancer: right concept, disappointing result. (1999) (4)
Linking lifestyle with microbiota and risk of chronic inflammatory disorders (2009) (4)
Gene-targeted immunologic knockouts: New models of inflammatory bowel disease (1994) (4)
Closing in on the genetics of Crohn's disease. (1996) (4)
Inflammasome Signaling Regulates the Microbial–Neuroimmune Axis and Visceral Pain in Mice (2021) (4)
Altered expression of fas ligand by colonic epithelium in Crohn's disease and ulcerative colitis (1998) (3)
Factor V deficiency and its reversal with gluten restriction. In a patient with celiac disease. (1983) (3)
Book Review Colonic Diseases Edited by Timothy R. Koch. 553 pp., illustrated. Totowa, N.J., Humana Press, 2003. $175. 0-89603-961-7 (2004) (3)
A Convolutional Neural Network Deep Learning Model Trained on CD Ulcers Images Accurately Identifies NSAID Ulcers (2021) (3)
Immunologic response to a novel probiotic organism in patients with active Crohn's disease (2000) (3)
Role of antibiotics and probiotics in the management of inflammatory bowel disease (2003) (3)
Role of the CD45 (T-200) molecule in anti-CD3-triggered T cell-mediated cytotoxicity. (1988) (3)
The neglected spectrum of diverticular-related disorders. (2013) (3)
Effects of the intestinal microbiota on behavior and brain biochemistry. (2013) (3)
Colorectal cancer: still a major killer despite progress on many fronts. (2000) (3)
The metabolic role of the microbiota (2015) (3)
85 The Vexed Relationship Between Clostridium difficile and Inflammatory Bowel Disease (IBD) - a Prospective Assessment of Carriage in An Outpatient Setting in Patients in Remission (2008) (3)
Mutant salmonella as vectors for gene therapy. (2001) (3)
Constitutive ERK 1 / 2 Activation in Esophagogastric Rib Bone Marrow (2001) (3)
Letter: dietary fibre benefits for the oesophagus—physical rather than metabolic action? Authors’ reply (2019) (3)
Influence of bifidobacterium infantis feeding on secretagogue response and gut barrier function in rats recovering from colitis (2003) (3)
A multicentre analysis of Clostridium difficile in persons with Cystic Fibrosis demonstrates that carriage may be transient and highly variable with respect to strain and level: Cystic Fibrosis and Clostridium difficile. (2021) (3)
Editorial: probiotics in inflammatory bowel disease—wrong organisms, wrong disease, or flawed concepts? (2017) (3)
Regulation of Myelination in the Prefrontal Cortex by the Gut Microbiota: Implications for Health and Disease (2015) (3)
Designer drugs for inflammatory bowel disease. (1997) (3)
Strategy for the maximization of clinically relevant information from hepatitis C virus, RT-PCR quantification. (2001) (3)
Glial cells, mucosal integrity, and inflammatory bowel disease. (1999) (3)
Intestinal graft-versus-host disease. (1998) (3)
p53 at the crossroads of colitis and cancer. (2001) (3)
Effect of probiotic and vitamin D supplementation on markers of vitamin D status and bone turnover in healthy adults (2009) (3)
Modulation, microbiota and inflammation in the adult CF gut: A prospective study. (2022) (3)
CD 38 is associated with premenopausal and postmenopausal bone mineral density and postmenopausal bone loss (3)
663 A Secreted Polysaccharide from Bifidobacterium Infantis 35624 Promotes Development of FOXP3+ T Regulatory Cells in Gnotobiotic Mice In Vivo. (2009) (3)
Pathogen Citrobacter rodentium and Systemic Infection with the Enteric Natural Killer Cells Protect against Mucosal (2013) (2)
The impact of probiotics in obese pregnancy to reduce maternal fasting glucose: A randomized controlled trial (2014) (2)
400 Differential Expression of Toll-Like Receptors (TLRS)in Irritable Bowel Syndrome (IBS) (2009) (2)
Therapeutic Manipulation of the Microbiota in Inflammatory Bowel Disease: Antibiotics and Probiotics (2010) (2)
Gene therapy for food allergy. (2000) (2)
Prostaglandin E 2 stimulates Fas ligand expression via the EP 1 receptor in colon cancer cells (2019) (2)
RT-PCR for the assessment of genetically heterogenous populations of the hepatitis C virus. (2002) (2)
Chapter 22 – Translating Microbiome Science to Society—What’s Next? (2016) (2)
Non-linkage of a T-cell receptor gamma chain microsatellite (D7S485) to rheumatoid arthritis in multiplex families. (1995) (2)
Stem cell factor and intestinal lymphoepithelial communication. (1995) (2)
How the Irish savoured gastroenterology: a literary reinterpretation of the alternative history. (2015) (2)
Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease (2007) (2)
W1634 Enteric Bacterial Signalling Overrides Cytokine Signalling and Modifies Dendritic Cell Differentiation (2009) (2)
Cadherins, inflammatory bowel disease, and neoplasia. (1996) (2)
A potential role for the immune system in gastric acid secretion and peptic ulcer disease. (1993) (2)
Bacterial DNA within granulomas of patients with Crohn's disease-detection by laser capture microdissection and PCR (2003) (2)
Lack of an association between polymorphisms of the T-cell receptor alpha-chain and ulcerative colitis. (1989) (2)
The utilisation and diagnostic yield of radiological imaging in a specialist functional GI disorder clinic: an 11-year retrospective study (2014) (2)
Neurotransmitter induction of glial cell cytokines (1993) (2)
Probiotics: A Clinical Guide, Martin H. Floch, Adam S. Kim (Eds.). Slack, Inc, Thorofare, New Jersey (2010), 352 pp. $83.95, ISBN: 13-978-1-55642-909-5. Web site for ordering: www.slackbooks.com (2011) (2)
Who Is the Responder to Probiotic Therapy in IBS? Data from a Controlled Clinical Trial with Bifidobacterium infantis 35624: 887 (2005) (2)
The gastrointestinal system and psychological factors (1999) (2)
WS16.1 Clinical Outcomes of Real-World Kalydeco (CORK) study – Investigating the impact of CFTR potentiation on the intestinal microbiota, exocrine pancreatic function and intestinal inflammation prospectively over 12 months (2015) (2)
Editorial: probiotics and IBS – where are we now? (2014) (2)
Escape from the Smad world by colon cancer. (1999) (2)
Appropriateness of laboratory tests: Requests for atypical pneumonia serology in a teaching hospital (1996) (2)
1058 Tryptophan Catabolism in Irritable Bowel Syndrome: Relationship to Cytokines, Severity and Psychiatric Co-Morbidity (2008) (2)
Food allergies (2002) (2)
Cyclosporine and inflammatory bowel disease: still more questions. (1995) (2)
Safety of low-dose purine analogues in inflammatory bowel disease. (1994) (2)
Crohn's Disease Derived Mononuclear Cells Exhibit a Dysregulated Cytokine Response upon In-Vitro Exposure to Mycobacterium Avium Subspecies Paratuberculosis (MAP) (2006) (2)
Confirmation of the Fas counterattack in host-tumor relations. (1997) (2)
Infographic. Athlete health and performance: no guts no glory (2019) (1)
Purine analogues and Crohn's disease: learning more about the long-term. (1996) (1)
Role of Natural Effector Cells in Human Gastrointestinal Disease (1989) (1)
Metatranscriptomics of colonic lesions in inflammatory bowel disease (2015) (1)
The effects of probiotic supplementation on gut microbiota composition, immunological and biochemical markers in healthy volunteers (2010) (1)
Fiber-associated Lachnospiraceae reduce colon tumorigenesis by modulation of the tumor-immune microenvironment (2021) (1)
W1844 Bifidobacterium Animalis Ahc7 Protects Against Pathogen-Induced NF-κB Activation In Vivo (2010) (1)
Author response: Social interaction-induced activation of RNA splicing in the amygdala of microbiome-deficient mice (2018) (1)
Evidence of association between the gene regulated by oestrogen in breast cancer 1 and variation in bone mineral density in Caucasians (2009) (1)
Probiotic Use Results in Normalization of Bowel Movement Frequency in IBS. Results from a Clinical Trial with the Novel Probiotic Bifidobacteria infantis 35624: 888 (2005) (1)
Crohn's disease: to lump or to split? (1995) (1)
The Placebo Effect: is achieving trial success all in our minds? (2017) (1)
The Gut Microbiota – A Realistic Therapeutic Target in Obesity and Metabolic Dysregulation (2011) (1)
Bone-marrow micrometastases in patients with brain metastases from epithelial cell tumours. (2000) (1)
Gastrointestinal Manifestations of Immunological Disorders (2009) (1)
Neurokinin Antagonism and Chemotherapy-Induced Emesis (1999) (1)
Cytokine induced expression of substance P (NK-1) receptors in human colonic epithelial cells* (1998) (1)
Immunosppressive Agents in Inflammatory Bowel Disease: Current Status and Future Prospects (1994) (1)
Faecal Microbiota Transplantation (FMT) - classical bedside-to-bench clinical research. (2019) (1)
From bugs to drugs—Mining the gut microbiota (2008) (1)
Bile tolerance and bile salt hydrolase activity of lactobacilli and bifidobacteria isolated from the human intestine (1995) (1)
WS3.5 Clostridium difficile in adult cystic fibrosis (CF): Prevalence, ribotyping and toxigenic capability. A prospective study (2013) (1)
Transplanting microbes for irritable bowels or irritated microbes or both? (2020) (1)
Food Allergy and Adverse Reactions (1986) (1)
Differentiation- Associated oftheEpstein-Barr Virus BZLF1Transactivator Protein inOralHairy Leukoplakia (1991) (1)
The Brain-Gut Axis and the Mucosal Immunoinflammatory Response (1995) (1)
Sa1870 MiR-375 is a Key Regulator of Intestinal Homeostasis in Response to Inflammatory Stress (2012) (1)
Su2001 Altered Expression and Activation of the CXCR3/CXCL10 Chemokine System in Irritable Bowel Syndrome (IBS) Mucosal Biopsy Tissue (2012) (1)
A Prospective Trial of Low-Dose Abdominal Computerised Tomography (CT) With Iterative Reconstruction vs Conventional CT in Crohn's Disease (2011) (1)
The effect of short-term phylloquinone supplementation on indices of vitamin K status and bone turnover in adult patients with Crohn's disease (2009) (1)
Immunosuppressive agents in IBD: current status and future prospects (1994) (1)
Probiotics: A Role in Therapy for Inflammatory Bowel Disease (2006) (1)
Portrait of a Canine Probiotic – from Gut to Gut (2009) (1)
Esophagogastric cancer—time to change the paradigm (2000) (1)
The effect of immunosuppression on patch testing: A cross‐sectional study in patients with inflammatory bowel disease (2021) (1)
Angiostatin: candidate for molecule of the year! (1995) (1)
Bone marrow micrometastases in oesophago-gastric cancer — Evidence for clearance in patients receiving neoadjuvant chemoradiotherapy (2002) (1)
How do intestinal T cells sense the dietary and microbial environment? (2000) (1)
Mechansims Underpinning Successful Faecal Microbiota Transplantation (FMT) for Recurrent Clostridium Difficile Infection (2017) (1)
Clinical Examination of the Gastrointestinal System in the 21st Century—Is the Emphasis Right? (2004) (1)
MiR-146a Negatively Regulates IL-17A Inflammatory Response and is Elevated in Intestinal Epithelial Cells From Inflammatory Bowel Disease (IBD) Patients (2011) (1)
Colitis-associated cancer and dysplasia surveillance: An opposing perspective (2007) (1)
Author response: linking lifestyle and microbes (2014) (1)
Immuno-epithelial interactions: Cytokine modulation of normal rabbit colonocyte function (1998) (1)
The chemotherapeutic agent N-acetyl-L-cysteine (NAC) decreases insulin-like growth factor I receptor (IGF-IR) and epidermal growth factor receptor (EGFR) levels on colorectal cancer cell lines (2004) (1)
Publisher Correction: Language, numeracy and logic in microbiome science (2019) (1)
43 The Role of T Cells in Vagal Protection Against Intestinal Inflammation (2008) (1)
Method and bias (2001) (1)
Elevated Soluble Interleukin 2 Receptor Levels in Patients with Schizophrenia (1998) (1)
Celiac disease and Addison's disease — a clinical pitfall (2000) (1)
Su2044 Evidence of on-Going Activation of the CXCR3 Chemokine System in Irritable Bowel Syndrome (IBS) (2014) (1)
Su1992 Regulation of Serotonergic Neurotransmission and Behaviour by the Brain-Gut-Microbiome Axis (2012) (1)
Effective therapy for advanced gastrointestinal stromal tumors. (2003) (1)
Bad language in gastroenterology (2008) (1)
Mo1098 Differential Expression of Epigenetic Modifier Genes in Inflammatory Bowel Disease Colonic Tissue - PRDM1 and PRDM8 are up-Regulated in Active Ulcerative Colitis (2012) (1)
260 Alterations in the Microbiota in Irritable Bowel Syndrome; A Comparison of Two Geographically Distinct Cohorts (2016) (1)
Gender-dependent influence of the gut microbiome on the hippocampal 5-HT system (2010) (1)
Functional Foods and Gastrointestinal Disorders (2006) (1)
Evidence for immune evasion by the ‘Fas counterattack’ in vivo in esophageal cancer* (1998) (1)
Iconographies supplémentaires de l'article : Impact of probiotics in women with gestational diabetes mellitus on metabolic health: a randomized controlled trial (2015) (1)
Innate resistance to Listeria monocytogenes in tumor‐bearing mice (1997) (1)
When to suspect contamination rather than colonization – lessons from a putative fetal sheep microbiome (2021) (1)
Interactions between Medications and the Gut Microbiome in Inflammatory Bowel Disease (2022) (1)
DNA sensor associated type I Interferon signalling is increased in ulcerative colitis and induces JAK-dependent inflammatory cell death in colonic organoids. (2022) (1)
Quantitative analysis of mucosal oxygenation using ex vivo imaging of healthy and inflamed mammalian colon tissue (2016) (1)
The nonindustrialised microbiome in a modern world. (2022) (1)
Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E−/− mice (2017) (1)
Dietary-Induced Bacterial Metabolites Reduce Inflammation and Inflammation-Associated Cancer via Vitamin D Pathway (2023) (1)
Epithelial cytoprotection is part of the therapeutic effect of interleukin-10 in mucosal inflammation* (1998) (0)
965 The Brain-Gut-Microbiome Axis: Gender and Region-Specific Effects of the Microbiome on Central Neurotransmitter and Neurotrophin Levels (2010) (0)
Plasticity of epithelial cell cytokine responses to commensal and pathogenic species (2003) (0)
The Discriminatory Intelligence of M Cells – Beyond a Simple Translocation Portal (2011) (0)
M1181 Mechanism of Epithelial CCL20 Response to Listeria (2008) (0)
Alimentary Pharmabiotics : Common Ground for Academia with the Food and Pharmaceutical Industries (2011) (0)
Mycobacterium Aviumparatuberculosis in Crohn's Disease: Player Or Spectator? (2007) (0)
Title Minimization of radiation exposure due to computed tomography in inflammatory bowel disease (2019) (0)
S1652 The Effect of the Farnesoid X Receptor (FXR) and It's Agonist - GSK488062B - On Experimental Models of Colitis and Cytokine Production from IBD Tissue (2009) (0)
Opportunistic Pathogens in Inflammatory Bowel Disease and the Relation with Specific Gene Susceptibilities (2014) (0)
A search for mycobacterium paratuberculosis by PCR in Crohn's granulomas isolated laser capture microdissection (2001) (0)
W1972 COX-Derived PGE2 Modulates Fasl Expression Via the Ep1 Receptor in Colon Cancer Cells (2008) (0)
Microbially mediated bile alterations affects host metabolism (2015) (0)
Strains of Lactobacillus casei (2002) (0)
Fas ligand expression by normal human esophageal squamous epithelium: Another site of immune privilege (1998) (0)
Intestinal tuberculosis – a case series mimicking as inflammatory bowel disease (2006) (0)
The sustained trajectory of small bowel research. (2014) (0)
Generation of mucosal mast cells in vitro from the mesenteric lymph node (1984) (0)
Shanahan's Response to Hayman Regarding Darwinian Dyspepsia (2012) (0)
Diagnosis and Implications of Bone Marrow Micrometastases (2001) (0)
W1167 Activation and Modulation of the MAP Kinase Pathway in IBD (2008) (0)
Human Esophageal Carcinoma Associated with Fas Ligand Expression by Depletion of Tumor-Infiltrating Lymphocytes The Fas Counterattack In Vivo : Apoptotic (1998) (0)
122 Modulation of cystic fibrosis gut inflammation – a pivotal role of the lung gut axis? (2014) (0)
lrnrnunosuppressive and immunomodulatory therapy for inflammatory bowel disease (2016) (0)
Thrombosis, factor V Leiden, and inflammatory bowel disease. (1999) (0)
Molecular hla class ii associations with the various forms of inflammatory bowel disease ibd (1991) (0)
Carbohydrate Syntrophy enhances the establishment of Bifidobacterium breve UCC2003 in the neonatal gut (2018) (0)
Thiopurine Methyltransferase Genotype Distribution in Irish Patients with Crohn's and Ulcerative Colitis: A Frequency Study (2006) (0)
Exploring the link between gut microbes and obesity (2007) (0)
Cytotoxic lymphocytes in human intestinal mucosa. (1987) (0)
409 The Colonic Adherent-Invasive Escherichia coli Strain HM605 Induces Anti-Apoptotic Responses in Intestinal Epithelial Cells, Reduces Barrier Integrity and Worsens Experimental Colitis (2014) (0)
Prevalence of 5-ASA Use in Diverticulitis and Diverticulosis by Age and Gender: 371 (2007) (0)
WS03.3 A longitudinal, multi-centre investigation into the gut microbiota of adult CF patients – the CFMATTERS perspective (2017) (0)
The Immunomodulatory Drug FTY720 Prevents Clearance of Citrobacter rodentium Infection in Mice (2011) (0)
Sa1681 Inhibition of the Prostaglandin EP1 Receptor Suppresses Colon Cancer Cell Invasion and Metastasis. (2013) (0)
Tumor Immune Privilege Human Breast Cancers : Significance for Expression of Fas ( CD 95 / APO-1 ) Ligand by (1999) (0)
Microbial regulation of microRNA expression in the amygdala and prefrontal cortex (2017) (0)
Irritable Bowel Syndrome Rates Following Organic Disease of Upper and Lower Gastrointestinal Tract: 1315 (2010) (0)
DOP017 Dysbiosis in ulcerative colitis: adding the spatial component (2014) (0)
M1329 Quantification of Gastro-Intestinal Gas Volume by CT: Increased With Age but Not in Functional Gastro-Intestinal Disorders. (2010) (0)
Title The microbiome regulates amygdala-dependent fear recall (2018) (0)
Prostate Radiotherapy Is Associated With Second Cancers in Many Organs, not Just the Colorectum (2005) (0)
Oral Administration of the Probiotic Bifidobacterium Infantis 35624 to Humans Induces Immunoregulatory Responses In Vivo: 1228 (2011) (0)
Prostate Radiotherapy Is Associated With Second Cancers in Many Organs, not Just the Colorectum (2005) (0)
Rheumatoid arthritis - aetiopathogenesis and animal models 87. Do We Need to Redefine Seropositivity in RA? (2011) (0)
Mechanisms of Adherence of aProbiotic LactobacillusStrain during and afterin vivoAssessment in Ulcerative Colitis Patients (2004) (0)
M1760 Bifidobacteria Attenuate the Development of Non-Alcoholic Fatty Liver in Obese Mice (2008) (0)
Recovery from Lipopolysaccharide Tolerance Macrophage-Polarization State following Identification of a Unique Hybrid (2013) (0)
49. Ulcerative Colitis (2012) (0)
Beneficial influence of bifidobacterium infantis feeding on secretagogue response in rats recovering from colitis (2005) (0)
Pharmabiotics and Inflammatory Bowel Disease ‒ On the Verge of Evidence‐based Medicine (2008) (0)
Author response: Microbiota regulates visceral pain in the mouse (2017) (0)
Intestinal Effects of Bacterial Chemotactic Peptides: Induction of Inflammation, Release of Eicosanoids. (2020) (0)
Upregulation of Fas-FasL (CD95/CD95L)-mediated epithelial apoptosis in pouchitis (2001) (0)
THU0099 The localisation of flice inhibitory protein (flip) in rheumatoid synovium (2001) (0)
Inflammatory bowel disease: rationale for therapeutic focus on gut flora (2002) (0)
PHARMACOLOGY (1992) (0)
S1677 The Gut Microbiota As An Environmental Regulator of Regulatory T Cells and Antigen Presentation Function of Dendritic Cells. (2009) (0)
Commensal bacteria exert immunomodulatory activities on human intestinal immune cells (2006) (0)
Immunosuppressive agents in inflammatory bowel disease : Current status and future prospects (2016) (0)
Don’t forget increased risk of fetal growth restriction (2009) (0)
Separating the microbiome from the hyperbolome (2015) (0)
M1782 Bacterial Translocation-Modelling Differential Rates of Sampling and Uptake of Various Species of Enteric Commensals (2010) (0)
INFLAMMATORY BOWEL DISEASE PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser capture microdissection (2002) (0)
The chemopreventative agent N-acetyl-L-cysteine (NAC) decreases epidermal growth factor receptor (EGFR) levels on colonic carcinoma cell lines (2001) (0)
THE SYNTHETIC GLYCAN KB295 OPTIMIZES MICROBIOME COMPOSITION AND FUNCTION IN ULCERATIVE COLITIS – RESULTS FROM A PROOF OF PRINCIPLE HUMAN STUDY (2022) (0)
Response to Dr. Gonzalez Cueto (2001) (0)
The effect of vitamin K1 supplementation for 12 months on bone mineral density and indices of vitamin K status and bone turnover in adult Crohn's disease patients (2011) (0)
T1807 Bacterial Proteolytic Profile in Inflammatory Bowel Diseases (2010) (0)
A Case of Herpes and Candidal Esophagitis: The Diagnostic Importance of Endoscopy in Odynophagia and Fever: 534 (2009) (0)
Cystic Fibrosis Lung Airway Cells in the Murine Lung and on Pseudomonas aeruginosa NH4 Can Eliminate φ MR 299-2 and φ Bacteriophages 2012 (2019) (0)
Detection of Mycobacterium avium subspecies paratuberculosis in patients with Crohn’s disease is unrelated to the presence of single nucleotide polymorphisms rs2241880 (ATG16L1) and rs10045431 (IL12B) (2014) (0)
Sa1797 Altered Immunometabolism As a Result of Colonic Inflammation and Westernized Diet in Experimental Models of Colitis and Colitis-Associated Colorectal Cancer (2015) (0)
Making computed tomography safer for patients with Crohn’s disease (2021) (0)
MAP, Milk and Man (2007) (0)
A search for Mycobacterium paratuberculosis by PCR in Crohn’s granulomas isolated by laser capture microdissection (2002) (0)
A model for Hepatitis C Virus (HCV) Expression in Cell Culture (2006) (0)
Investigating physiological variation in healthy Irish adults using a combination of traditional techniques and emerging metabolomic technologies (2010) (0)
For personal use. Only reproduce with permission from The Lancet Publishing Group. (2002) (0)
IGF-1 protects colonic epithelial cells from cytokine induced apoptosis by maintaining cellular phospho-tyrosine content and preventing cytochrome C release (2001) (0)
An IBD-associated pathobiont synergises with NSAID to promote colitis which is blocked by NLRP3 inflammasome and Caspase-8 inhibitors (2022) (0)
Viral discrimination and subversion of host defense at the epithelial gateway. (2002) (0)
T1718 Natural Killer Cell Responses in Both Acute and Chronic Phases of a Murine Model of Experimental Colitis (2009) (0)
48 Altered gut microbiota in stable patients with cystic fibrosis (CF) compared to controls and its relationship with intravenous (IV) antibiotic usage and lung function (2015) (0)
Changes in the immunoregulatory gene profile in ibs subjects following probiotic treatment: investigating a mechanism of action (2006) (0)
Alteration in the Ratio of cMyc to Mutant p53 is a Phenotypic Trait of Epithelial Cells Committed to Die by Apoptosis (2000) (0)
P493 The synthetic glycan KB295 optimises microbiome composition and function in ulcerative colitis: Results from a proof of principle human study (2022) (0)
Human BCL-G regulates secretion of inflammatory chemokines but is dispensable for induction of apoptosis by IFN-γ and TNF-α in intestinal epithelial cells (2020) (0)
Probiotic strains of the genus Lactobacillus salivarius (2002) (0)
Tu1843 Deficiency in ATG16L1 Increases the Ability of the Adherent-Invasive Escherichia coli (HM605) to Replicate in and Reduce Barrier Integrity of Intestinal Epithelial Cells (2012) (0)
19 – Synbiotics and colon cancer (2004) (0)
What's Hot in the Red Journal This Month? (2010) (0)
Targeting the EP1-FasL Signaling Pathway Reduces Colon Tumor Cell Growth In Vivo (2011) (0)
Fas activates the AP-1 transcription factor via the ERK1/2 and p38 MAPK pathways (2003) (0)
Probiotic-induced immunomodulation in lymphoid compartments of IL-10 knock-out mice prior to onset of inflammation (2006) (0)
Micrometastases and residual disease Bone marrow micrometastases before and after ' curative ' resection of a primary gastrointestinal tumour Micrometastases Development of overt metastases within Preoperative (0)
In Search of Lost Opportunities (2012) (0)
Modulation of gastrointestinal epithelium by a local neuroimmune network of substance P and cytokines (2000) (0)
Serum viral load and clincopathologic progression of hepatitis C (1b): A study in a homogenous patient population* (1998) (0)
Microbiome and health implications for ethnic minorities after enforced lifestyle changes (2020) (0)
Biotinylated Neuropeptide Analogs: Design and Use as Probes for Target Cells in Heterogeneous Populations (1993) (0)
Tu1247 The Relationship Between Cystic Fibrosis Epithelial Cells and Intestinal Inflammation -Evolving Mechanisms of the Lung-Gut Axis (2014) (0)
Selection of a probiotic strain to modify human gut flora and a controlled trial of delivery and efficacy (1998) (0)
Enterotypes in the landscape of gut microbial community composition (2017) (0)
WS07.6 Investigating the gut microbiota of patients with cystic fibrosis (PWCF) and the effects of an altered gut microbiota on functionality and faecal metabolites – the CFMATTERS experience (2016) (0)
M1349 ROME II Versus ROME III; Impact on Subtyping and Prevalence of Psychiatric Co-Morbidity in Irritable Bowel Syndrome (IBS) (2010) (0)
Transplantation immunology and the gut (2001) (0)
OC1.04.3 ACTIVATION AND MODULATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE PATHWAY IN INFLAMMATORY BOWEL DISEASE (2008) (0)
Enteropathogenic E. coli: intimacy redefined. (1998) (0)
Bcl-3 deficiency protects against DSS-induced colitis in the mouse 1 (2013) (0)
Epilogue: Bench to bedside and back to bench (2003) (0)
Improved fracture prediction when the FRAX® tool is used in combination with vertebral morphometry (2009) (0)
Differential cytokine response of cells derived from different lymphoid compartments to commensal and pathogenic bacteria (2003) (0)
Abstracts of the Hans Selye Symposium on Neuroendocrinology and Stress (1989) (0)
Erratum to: The altered gut microbiota in adults with cystic fibrosis (2017) (0)
Fast Facts: Inflammatory Bowel Disease for Patients and their Supporters (2019) (0)
Crohn’s Disease: Minimizing Radiation Dose (2013) (0)
Radiation Exposure in IBD: How do we Minimize the Dangers? (2012) (0)
We acknowledge patients and their families, and thank family recruitment doctors: (2001) (0)
P.1.c.004 The microbiota–gut–brain axis regulates adult hippocampal neurogenesis (2014) (0)
Who needs doctors? Staying fresh in changing times. (2011) (0)
Tu1677 Upregulation of Fas Ligand Expression Promotes Colon Cancer Cell Migration and Metastasis In Vitro and In Vivo (2014) (0)
Skin contact, skin radiant (2013) (0)
Ocular Immunity and Tolerance (2009) (0)
Thromboembolic Disease: An Under‐Recognized Complication? (2007) (0)
THU0121 Bcl-xl and plasma cell survival in rheumatoid synovium (2001) (0)
Probiotics and Health Claims (2011) (0)
Visualising Bacterial Colonization Dynamics Inside the Gut Using Upconverting Nanoparticles Luminescence Imaging (2018) (0)
Stimulation of T-Cells in Irritable Bowel Syndrome (IBS) Mucosal Biopsy Tissue Releases Cytokines Which Selectively Activate Submucosal Neurons (2011) (0)
T1032 Patients with Functional Gastro-Intestinal Disorders May Be Exposed to Significant Amounts of Medical Radiation. (2009) (0)
Response to Andrews et al. (2010) (0)
Human microbiome variance is underestimated. (2023) (0)
Fibrocytes contribute to mesenteric manifestations in Crohn s disease (2016) (0)
273 High Fat Feeding Alters Gut Microbiota and Protects Mice From Colitis and Colitis-Associated Colorectal Cancer (2014) (0)
68 The bifidobacterium longum 35624® culture transits in high numbers through the human gut (2017) (0)
Fecal microbiota-based treatment for recurrent Clostridioides difficile infection (2023) (0)
Ethereal and material gain: unanticipated opportunity with illness or disability. (2014) (0)
Abstracts from Digestive Disease Week, May, 2006 Development of Strain-Specific Molecular Method for the Identification of Bifidobacteria infantis 35624 (2006) (0)
Diversity of epithelial cell gene expression in response to different lactobacilli (2003) (0)
Publisher Correction: Enterotypes in the landscape of gut microbial community composition (2018) (0)
Sa1925 Cross-Talk Between Gamma-Aminobutyric Acid and Prostaglandin E2 in Colon Carcinogenesis (2015) (0)
Maximal activation of epithelial NFKB — an additional molecular mechanism underlying synergy between IFN-Г and TNF-a (2000) (0)
Fas ligand expressed in colon cancer is associated with suppression of activation and IL-2 production in tumor-infiltrating T-cells (2001) (0)
742 Modification of Lymphocyte Trafficking in An In Vivo Model of IBD Following Administration of a Novel Alpha 4 Integrin Antagonist (2008) (0)
Quantitation and Localization Peripheral Mononulear Cells: Molecular Marker of Human Mucosal But Not Substance P (Neurokinin-1) Receptor Is a (1998) (0)
Interpersonal variability of the human gut virome confounds disease signal detection in IBD (2023) (0)
WS13.2 The role of PGE2 in cystic fibrosis (CF) lung inflammation and the potential association with ivacaftor therapy and treatment response (2015) (0)
Tu1978 Bifidobacterium Infantis 35624 Administration and Peyer's Patch Immune Response Following Salmonella Infection: The Role of Regulatory T-Cells and Chemokine Secretion (2013) (0)
Purine analogues and ulcerative colitis. (1993) (0)
Once a celiac, always a celiac...sometimes not? (2000) (0)
S1222 Thuricin CD, an Alternative or Supplementary Treatment for C. difficile -Narrower Spectrum of Activity Against Commensal Microbiota. (2010) (0)
Tu1679 Role of ST2 and Its Ligand, IL-33, in Colon Cancer (2014) (0)
Medicine in the Age (2006) (0)
Probiotics by the parenteral route-efficacy in murine colitis and arthritis (2003) (0)
RATIONAL SELECTION OF LACTOBACILLUS STRAINS BASED ON BILE SALT HYDROLASE ACTIVITY (2016) (0)
M1805 Synergy Between Fas and TLR4 in Promoting Pro-Inflammatory Cytokine Synthesis in Macrophages and Intestinal Epithelial Cells – Relevance to IBD (2010) (0)
Translating the microbiome - what's the target? (2023) (0)
1017 The Metabolic Activity of the Enteric Microbiota Influences the Fatty Acid Composition of Host Tissues (2008) (0)
The Effect of Activated Inflammatory Cells on Colonic Smooth Muscle Contraction (2020) (0)
S1705 In Vivo Imaging of a Probiotic-Mediated Regulatory T Cell Response Following Adoptive Transfer (2008) (0)
A mechanism for esophageal tumor-derived immunosuppression. (1994) (0)
The Host Immune Response to Clostridium Difficile and the Immunomodulatory Effects of Probiotic Bacteria in Vitro (2006) (0)
The thi cytokines IFN-Г and TNF-a reactivate components of the p53 pathway in mutant p53 epithelial cells (2000) (0)
TITLE: Exercise and the microbiota (2015) (0)
Surges in Circulating Interleukin-6 and Transforming Growth Factor-β Associated with Exercise in Patients with COPD Are Attenuated by Pulmonary Rehabilitation. (2009) (0)
Probiotics — Separating Science From Snakeoil (2007) (0)
P.597 The gut microbiome and tryptophan metabolism: focus on gastrointestinal and hepatic gene expression (2020) (0)
Parathyroid hormone receptor type 1 polymorphisms are not associated with BMD variation in a caucasian cohort (2010) (0)
Tu1775 Spatial Mapping of the Microbiota in Ulcerative Colitis (2014) (0)
Correction to: Piphillin predicts metagenomic composition and dynamics from DADA2- corrected 16S rDNA sequences (2020) (0)
Pro-inflammatory cytokines suppress p53 function in colonic epithelial cells — A link between inflammation and tumorigenesis (2001) (0)
Bone marrow micrometastases as a mechanism of anemia of chronic disorders in gastrointestinal cancer (2000) (0)
IFN-γ and TNF-α Synergise to Induce Expression of the Novel PRO-Apoptotic Gene BCL-G and Apoptosis in Intestinal Epithelial Cells and BCL-G Expression is Reduced in Inflammatory Bowel Disease (IBD) and Colon Cancer (2011) (0)
Bifidobacteria for the treatment of inflammatory disease (2000) (0)
Fiber man meets microbial man 1 – 3 (2014) (0)
N-acetylcysteine (NAC) downregulates type I insulin-like growth factor receptor (IGF-IR) and epidermal growth factor receptor (EGFR) on colorectal carcinoma cell lines – possible mechanism underlying NAC-mediated chemoprevention and chemotherapy (2006) (0)
1109 NK Cells Protect Mice During Acute Experimental Colitis by Regulating Neutrophil Function via NKG2A-dependent Mechanisms (2012) (0)
Gastrointestinal gas volume measurement with CT: Patients with functional GI disorders have less gas (2010) (0)
28 Role of antibiotics and probiotics in the management of inflammatory bowel disease (0)
Genetics: Non-HLA genes (2003) (0)
Interleukin-8 secretion by human intestinal epithelial cells at physiological oxygen concentrations (2006) (0)
Cell receptor-ligand interaction, signalling, activation and apoptosis 21. Pregnenolone Sulphate is Similar to Dexamethasone in Supressing the Unfettered Secretion of Hyaluronan: In Vitro Study on Cultured Synovial Fibroblasts from Patients with Longstanding Rheumatoid Arthritis (2011) (0)
The Present and Future of Research and Treatment of Inflammatory Bowel Disease (2010) (0)
The fecal mycobiome in patients with Irritable Bowel Syndrome (2021) (0)
INFERRED HEPATITIS C VIRUS QUASISPECIES DIVERSITIES ARE PROFOUNDLY INFLUENCED BY CHOICE OF DNA POLYMERASE IN RT-PCR (2000) (0)
THE USE OF PLACEBOS IN CONTROLLED TRIALS. REPLY (1992) (0)
Advances in Inflammatory Bowel Diseases (Falk Symposium 106) (2001) (0)
Use of (bifidobacterium) in the treatment of inflammatory diseases. (2000) (0)
Changing phenotype of inflammatory bowel disease and neglected metabolic health (2021) (0)
A PROSPECTIVE STUDY OF COGNITIVE PERFORMANCE IN IRRITABLE BOWEL SYNDROME: VISUOSPATIAL MEMORY DEFICITS AS A STABLE FEATURE (2013) (0)
Mo1615 Targeting Fasl Increases the Anti-Tumor Immune Response in an In Vivo Model of Colon Cancer. (2012) (0)
Increasing diagnostic radiation exposure in patients with Crohn's disease from 1992 to 2006 (2008) (0)
Thanks ! Title The changing phenotype of Inflammatory Bowel Disease (2019) (0)
Ability of Bifidobacterium breve 702258 to transfer from mother to infant: the MicrobeMom randomised controlled trial. (2023) (0)
S1709 Control of Toll-Like Receptor (TLR) Signalling in Inflammatory Bowel Disease (IBD): Differential Expression of Key Regulators of TLRS in Ulcerative Colitis (UC) and Crohn's Disease (CD) (2009) (0)
Neutrophilic infiltration does not occur in FasL-expressing human colonic carcinomas, irrespective of TGF-b1 expression (2000) (0)
Bifidobacterium infantis Modulates Pathogen-Induced CCL20 Secretion by Human Intestinal Epithelial Cells (2006) (0)
In Search of Lost Opportunities: Marcel Proyce and James Joust Discuss Doctors, Diseases, Life and Death (a Hypothetical Conversation between Marcel Proust and James Joyce) (2012) (0)
Resolving the Fas counterattack controversy: Fas ligand promotes tumour immune evasion of colon cancer in vivo (2006) (0)
Safety of Bifidobacterium breve, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial. (2022) (0)
SETTING UP A FAECAL MICROBIOTA TRANSPLANTATION SERVICE: A QUALITY IMPROVEMENT PROJECT (2020) (0)
The Present and Future of Research and Treatment of Inflammatory Bowel Disease (2010) (0)
Title Role of radiologic imaging in irritable bowel syndrome : evidence-based review (2019) (0)
Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease (2020) (0)
A Mass Spectrometry Study of the Peptides Produced During the [i]in vivo[/i] digestion of α-lactalbumin (2013) (0)
A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis (2017) (0)
P040 Caspase-8 blockade attenuates NSAID-induced colitis and cell death via NLRP3 inflammasome and NF-κB activation (2023) (0)
7 – The therapeutic use of probiotics in gastrointestinal inflammation (2003) (0)
Introduction: Inflammatory bowel disease: from bench to bedside (2003) (0)
Outcome of childhood celiac disease: a 28-year follow-up (2003) (0)
Sa1818 Natural Killer Cells Contribute to Clearance of the Enteric Pathogen Citrobacter Rodentium Through Direct and Indirect Mechanisms (2013) (0)
946: KB295, A SYNTHETIC GLYCAN, AUGMENTS GUT MICROBIOME COMPOSITION AND FUNCTION IN ULCERATIVE COLITIS: UPDATED RESULTS FROM A PROOF OF PRINCIPAL HUMAN STUDY (2022) (0)
Field Sports Result in Fewer Serious Sporting Injuries in Children than Play or Active Recreation: 2017 (2006) (0)
Genetics : Non-HLA genes 194 . POLYMORPHISM SCREENING OF THE T LYMPHOCYTE SPECIFIC GLUCOCORTICOID RECEPTOR PROMOTER (2003) (0)
Gene array and functional analysis of micrometastatic cells from bone marrow (2000) (0)
244 MICROBIOME ANALYSIS OF UPPER DIGESTIVE TRACT BIOPSY SAMPLES FROM INDIVIDUALS ALONG THE METAPLASIA-DYSPLASIA-ADENOCARCINOMA SEQUENCE. (2021) (0)
Su2111 A Prospective Assessment of Cognitive Performance in Irritable Bowel Syndrome Reveals Persistent Visuospatial Memory Deficits (2013) (0)
Metatranscriptomics of colonic biopsies in inflammatory bowel disease (2014) (0)
Dysregulation of colonic epithelial Fas ligand expression occurs early in the adenoma-carcinoma sequence (1998) (0)
Tu1969 Elevated Expression of the Cytosolic DNA Sensors AIM2 and ZBP1/DAI in Active Ulcerative Colitis but Not Crohn's Disease Colonic Tissue (2012) (0)
Micrometastases in foregut cancer: High detection rate in rib marrow compared with iliac crest (1998) (0)
contentsof immunologic sensation of intestinal (2016) (0)
Dietary intakes and body composition in adult patients with long-standing Crohn's disease currently in remission (2008) (0)
Title Microbiota regulates visceral pain in the mouse (2019) (0)
W1862 The Effect of Diet, Genetic Background and Age on the Energy Harvesting Capacity of the Gut Microbiota in OB/OB and Diet-Induced Obese (Dio) Mice (2010) (0)
Response to Dr. Kuenstner: More About MAP (2006) (0)
Response to Sprakes et al. (2011) (0)
WS04.3 A comparison of Toll-like receptor mediated innate immune response in children with cystic fibrosis and an age matched control cohort (2016) (0)
587 A Computational Modelling Approach to Host-Microbe Interactions in the Gut: The in Silico Dendritic Cell Response to Microbes (2009) (0)
Su1966 An Assessment of Cognitive Function in Irritable Bowel Syndrome (IBS): Are Deficits in Visuo-Spatial Memory Stress-Related and Mediated by Tryptophan Metabolism Along the Kynurenine Pathway? (2012) (0)
Chronic gastroenterologic and hepatic disorders. (2007) (0)
Complementary Human mDC and pDC Mechanisms Ensure Induction of Foxp3+ T Cells in Response to the Commensal Microbiota: 1258 (2011) (0)
Bifidobacterium for treatment of inflammatory diseases (2000) (0)
185* Variability of toll like receptor mediated innate immune response in patients with cystic fibrosis and their relationship with clinical phenotype (2011) (0)
496 THE INFLAMMATORY-METAPLASIA-DYSPLASIA-OESOPHAGEAL ADENOCARCINOMA SEQUENCE: THE ROLE OF THE MICROBIOME (2020) (0)
S1765 Functionally Distinct LPS Responses in Peyer's Patch and Spleen Dendritic Cells are Underpinned by Differential TLR Regulation (2010) (0)
Sa1812 Spatial Biogeography of the Human Colonic Microbiota Reveals Distinct Luminal and Mucosal Communities (2013) (0)
Immunological disorders: (b) immunodeficiencies and gastrointestinal complications of organ transplantation (2015) (0)
Introduction: The Science and the Art of Inflammatory Bowel Disease (2010) (0)
The altered gut microbiota in adults with cystic fibrosis (2017) (0)
Su1939 Neuro-Immune Changes in IBS: A Link Between Microbiota, TLRs and Sensory-Related Markers? (2016) (0)
THU0014 Association between a polymorphism in the fractalkine receptor, CX3CR1, and rheumatoid arthritis (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Fergus Shanahan?

Fergus Shanahan is affiliated with the following schools:

National University of Ireland
University of Birmingham